Gail D'Onofrio Selected Research

Substance-Related Disorders (Drug Abuse)

1/2023	Computational phenotypes for patients with opioid-related disorders presenting to the emergency department.
12/2021	Implementation of Oral and Extended-Release Naltrexone for the Treatment of Emergency Department Patients With Moderate to Severe Alcohol Use Disorder: Feasibility and Initial Outcomes.
1/2021	Emergency department patients with untreated opioid use disorder: A comparison of those seeking versus not seeking referral to substance use treatment.
12/2020	Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder.
10/2020	Assessing the readiness of digital data infrastructure for opioid use disorder research.
8/2006	Intravenous morphine plus ketorolac is superior to either drug alone for treatment of acute renal colic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gail D'Onofrio Research Topics

Disease

31	Opioid-Related Disorders (Opiate Addiction) 12/2023 - 04/2015
7	Myocardial Infarction 01/2024 - 01/2017
6	Opiate Overdose 12/2023 - 12/2020
6	Substance-Related Disorders (Drug Abuse) 01/2023 - 08/2006
4	Pain (Aches) 10/2023 - 08/2006
4	Chest Pain (Chest Pains) 03/2019 - 06/2010
3	Heart Failure 05/2023 - 03/2014
3	Coronary Artery Disease (Coronary Atherosclerosis) 05/2023 - 02/2016
3	Acute Coronary Syndrome 11/2022 - 03/2014
2	ST Elevation Myocardial Infarction 01/2023 - 04/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 03/2014
2	COVID-19 01/2022 - 12/2020
2	Infections 01/2022 - 01/2021
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 02/2017
2	Obesity 03/2019 - 01/2018
2	Ischemia 03/2019 - 12/2014
2	Asthma (Bronchial Asthma) 01/2019 - 01/2018
1	Poisoning 11/2023
1	Headache (Headaches) 10/2023
1	Back Pain (Backache) 10/2023
1	Fatigue 01/2023
1	Genetic Risk Score 11/2022
1	Alcoholism (Alcohol Abuse) 12/2021
1	Diabetes Mellitus 01/2021
1	Hepatitis 01/2021
1	Neurotoxicity Syndromes (Toxic Encephalopathy) 01/2021
1	Hepatitis C 12/2020
1	Coronavirus Infections 12/2020
1	Inflammation (Inflammations) 03/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2019
1	Hypothyroidism 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Microvascular Angina (Cardiac Syndrome X) 01/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2014
1	Craniocerebral Trauma (Head Injury) 09/2011
1	Hypertension (High Blood Pressure) 06/2011
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2010
1	Stroke (Strokes) 11/2010
1	Syncope (Fainting) 11/2010
1	Altitude Sickness (Mountain Sickness) 01/2009
1	Seizures (Absence Seizure) 08/2006
1	Renal Colic 08/2006
1	Epilepsy (Aura) 08/2006

Drug/Important Bio-Agent (IBA)

24	Buprenorphine (Subutex)FDA LinkGeneric 12/2023 - 04/2015
16	Opioid Analgesics (Opioids)IBA 11/2023 - 02/2017
3	Biomarkers (Surrogate Marker)IBA 03/2019 - 12/2014
2	Methadone (Dolophine)FDA LinkGeneric 11/2023 - 01/2021
2	2- amino- 3- cyano- 6- ethyl- 5- (4- pyridyl)pyridineIBA 10/2023 - 01/2021
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2021 - 12/2020
2	Naloxone (Narcan)FDA LinkGeneric 12/2020 - 02/2017
2	LDL CholesterolIBA 01/2019 - 06/2011
2	CreatinineIBA 02/2016 - 03/2014
1	BenzodiazepinesIBA 10/2023
1	Fentanyl (Sublimaze)FDA LinkGeneric 10/2023
1	SilverIBA 01/2023
1	Clopidogrel (Plavix)FDA Link 11/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2022
1	Naltrexone (ReVia)FDA LinkGeneric 12/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Controlled SubstancesIBA 01/2021
1	Cocaine (Cocaine HCl)IBA 12/2020
1	hydroxide ionIBA 12/2020
1	ElementsIBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 03/2019
1	renalaseIBA 03/2019
1	Interleukin-33IBA 01/2018
1	RV 538 (PDMP)IBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	AntidotesIBA 02/2017
1	LipidsIBA 01/2017
1	Ranolazine FDA Link 01/2017
1	Naloxone Drug Combination Buprenorphine FDA Link 04/2015
1	2-aminoethylmethacrylate (AEM)IBA 12/2014
1	Phosphotransferases (Kinase)IBA 03/2014
1	TroponinIBA 03/2014
1	Peptides (Polypeptides)IBA 09/2011
1	oxidized low density lipoproteinIBA 06/2011
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 06/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2009
1	Opiate AlkaloidsIBA 08/2006
1	Analgesics (Analgesic Drugs)IBA 08/2006
1	Morphine (MS Contin)FDA LinkGeneric 08/2006
1	Illicit Drugs (Recreational Drugs)IBA 08/2006
1	KetorolacIBA 08/2006

Therapy/Procedure

4	Patient Readmission 01/2024 - 01/2023
3	Length of Stay 05/2023 - 01/2021
3	Therapeutics 01/2021 - 04/2015
1	Injections 12/2023
1	Percutaneous Coronary Intervention 01/2023
1	Cardiac Rehabilitation 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Critical Care (Surgical Intensive Care) 01/2019
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2014
1	Resuscitation 11/2010
1	Analgesia 08/2006
1	Contraindications 08/2006